article thumbnail

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

article thumbnail

DoH and Children’s National Hospital link for cell and gene therapy

Pharmaceutical Technology

Find out more The partnership will facilitate specialised fellowships, joint workshops and training programmes aimed at developing local talent. Go deeper with GlobalData Reports NPVM: Alaunos Therapeutics Incs Gene Therapy 2 for Oncology Reports NPVM: Alaunos Therapeutics Incs Gene-Modified Cell Therapy to Targ.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What Questions Did They Answer? (Part 1)

FDA Law Blog: Biosimilars

CBERs approach here was to take FAQs from across sponsor interactions, public workshops, email requests, etc. However, as your high-school literature teacher warned youto ace the test, you need to read the book, ahem, source regulations, guidance, or other policy documents.

article thumbnail

ICT Mumbai and Mumbai Biocluster host 5th Annual Summit on Biopharmaceutical Product Development

Express Pharma

The Institute of Chemical Technology, Mumbai, in partnership with the Mumbai Biocluster, hosted the 5th Annual Summit of Biologics Conference and Workshops on Biopharmaceutical Product Development from January 30th to 31st 2025.

article thumbnail

5th Oligonucleotides for CNS Summit

pharmaphorum

R&D Life Sciences Industry Report - Biologics and Generics The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems. You won’t want to miss out on this unique summit that is redefining the landscape of oligonucleotide research.

article thumbnail

HPM’s Larry Houck Presenting at WCF Opioid and Fentanyl Abuse Management Congress

FDA Law Blog: Biosimilars

Click here to learn more about the Opioid & Abuse Management Congress.

article thumbnail

Where Does Rare Disease and Patient-Focus Fall into Commissioner Makary’s Priorities & the MAHA Platform for FDA? A New Ultrarare Approval Pathway & More

FDA Law Blog: Biosimilars

We want to give FDA review officials the tools they need to be able to reduce barriers and customize what development looks like for ultra rare products (see, e.g., coverage of Frank Sasinowskis remarks at the May 21, 2024 EveryLife Foundation for Rare Diseases Scientific Workshop, Debating a new pathway for ultrarare ).